Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Immunofluorescence Assay Developed for Hantaviruses

By LabMedica International staff writers
Posted on 15 Apr 2013
Simultaneous tests were developed for clinically important Old and New World hantaviruses using multiparametric indirect immunofluorescence assays (IFAs) based on biochip mosaics. More...


To detect serum antibodies each of the mosaic substrates consisted of cells infected with one of the virus types Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Saaremaa (SAAV), Dobrava (DOBV), Sin Nombre (SNV) or Andes (ANDV).

Scientists from the Euroimmun Medizinische Labordiagnostika AG, ( Luebeck, Germany) in collaboration with others, analyzed 184 laboratory-confirmed Hantavirus-positive sera collected at six diagnostic centers from patients actively or previously infected with different Hantavirus serotypes. The control panel comprised 89 sera from healthy blood donors. The Euroimmun’s Hantavirus Mosaic 1 and 3 were used for the multiparametric IFA-based detection of Hantavirus-specific immunoglobulin G (IgG) and IgM.

The overall qualitative performance of multiparametric IFAs in detecting anti-Hantavirus antibodies was analyzed by considering those samples as seropositive that showed specific reactivity with a cut-off 1:100, against at least one of the different Hantavirus serotypes contained in the biochip mosaics. In the multiparametric IFA applied in the study, 99% of the patient sera were IgG positive and 71% were IgM positive. Overall IFA sensitivity for combined IgG and IgM analysis amounted to 100% for all serotypes, except for SNV, which was 96%. Of the 89 control sera, 2% showed IgG reactivity against the HTNV substrate, but not against any other Hantavirus.

The authors concluded that analysis of Hantavirus-specific IgG and IgM by indirect immunofluorescence on substrate mosaics consisting of cells infected with different hantaviruses is a globally applicable. The method is a reliable diagnostic tool for screening of patients suspected of having Hantavirus infection, and can be useful for serotyping in areas where hantaviruses of different serogroups are endemic. The multiparametric IFA enables highly sensitive and specific serological diagnosis of Hantavirus infections and can be used to differentiate PUUV and ANDV infection from infections with Murinae-borne hantaviruses such as DOBV and SEOV. The study was published on April 4, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Euroimmun Medizinische Labordiagnostika AG



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.